Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Feb 18, 2021 |
Director
Trans History: 66
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,424 | -- | 45,827 |
Feb 18, 2021 |
Director
Trans History: 7
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,424 | -- | 35,192 |
Feb 18, 2021 |
Director
Trans History: 79
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,424 | -- | 68,552 |
Feb 18, 2021 |
Director
Trans History: 98
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,424 | -- | 77,547 |
Jun 15, 2010 |
EVP, Chief Development Officer
Trans History: 186
|
EVP, Chief Development Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 19,550 | $21.01 | 24,740 |
Jul 02, 2013 |
EVP, CFO
Trans History: 176
|
EVP, CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 19,836 | $11.11 | 142,096 |
Jul 02, 2013 |
EVP, CFO
Trans History: 176
|
EVP, CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 19,836 | -- | -- |
Feb 21, 2013 |
EVP & Chief HR Officer
Trans History: 80
|
EVP & Chief HR Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,892 | -- | 34,360 |
Feb 21, 2013 |
EVP, GENERAL COUNSEL & SECRETA
Trans History: 93
|
EVP, GENERAL COUNSEL & SECRETA | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 19,892 | -- | 40,451 |
May 26, 2022 |
EVP, Chief Development Officer
Trans History: 186
|
EVP, Chief Development Officer | Form 4 | Open market or private sale of non-derivative or derivative security | 20,000 | $13.36 | 182,797 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.